JP2023553216A5 - - Google Patents
Info
- Publication number
- JP2023553216A5 JP2023553216A5 JP2023559969A JP2023559969A JP2023553216A5 JP 2023553216 A5 JP2023553216 A5 JP 2023553216A5 JP 2023559969 A JP2023559969 A JP 2023559969A JP 2023559969 A JP2023559969 A JP 2023559969A JP 2023553216 A5 JP2023553216 A5 JP 2023553216A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063123281P | 2020-12-09 | 2020-12-09 | |
| US63/123,281 | 2020-12-09 | ||
| PCT/US2021/062484 WO2022125711A1 (en) | 2020-12-09 | 2021-12-08 | Targeted cytokine construct for engineered cell therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553216A JP2023553216A (ja) | 2023-12-20 |
| JP2023553216A5 true JP2023553216A5 (https=) | 2024-12-10 |
| JPWO2022125711A5 JPWO2022125711A5 (https=) | 2024-12-10 |
Family
ID=81972793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559969A Pending JP2023553216A (ja) | 2020-12-09 | 2021-12-08 | 遺伝子操作細胞療法のための標的化サイトカイン構築物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240043490A1 (https=) |
| EP (1) | EP4259213A4 (https=) |
| JP (1) | JP2023553216A (https=) |
| KR (1) | KR20230129983A (https=) |
| CN (1) | CN116829194A (https=) |
| AU (1) | AU2021397271A1 (https=) |
| CA (1) | CA3201573A1 (https=) |
| WO (1) | WO2022125711A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116970059A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| TW202208395A (zh) | 2020-05-12 | 2022-03-01 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| WO2021231773A1 (en) | 2020-05-13 | 2021-11-18 | Good Therapeutics, Inc. | Compositions of protein complexes and methods of use thereof |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| EP4232071A4 (en) | 2020-10-23 | 2024-08-28 | Asher Biotherapeutics, Inc. | FUSIONS WITH CD8 ANTIGEN-BINDING MOLECULES TO MODULATE IMMUNE CELL FUNCTION |
| AU2022275666A1 (en) | 2021-05-19 | 2023-12-07 | Asher Biotherapeutics, Inc. | Il-21 polypeptides and targeted constructs |
| CN119744270A (zh) * | 2022-07-08 | 2025-04-01 | 盛禾(中国)生物制药有限公司 | 一种异源二聚体融合蛋白及其应用 |
| CA3262929A1 (en) * | 2022-07-25 | 2024-02-01 | Sloan-Kettering Institute For Cancer Research | PREPARATION PROCESSES FOR ADOPTIVE CELL THERAPIES |
| WO2025059162A1 (en) * | 2023-09-11 | 2025-03-20 | Dana-Farber Cancer Institute, Inc. | Car-engager containing il-2 variants to enhance the functionality of car t cells |
| CN117904196B (zh) * | 2024-01-05 | 2024-07-12 | 安徽大学 | 一种非小细胞肺癌组蛋白h1.4赖氨酸乙酰化点突变细胞模型的构建及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015117930A1 (en) * | 2014-02-06 | 2015-08-13 | F. Hoffmann-La Roche Ag | Interleukine 10 immunoconjugates |
| US20210017247A1 (en) * | 2017-07-03 | 2021-01-21 | Torque Therapeutics, Inc. | Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof |
| DK3661954T3 (da) * | 2017-08-03 | 2022-04-19 | Amgen Inc | Interleukin-21-muteiner og fremgangsmåder til behandling |
| JP2021516045A (ja) * | 2018-02-28 | 2021-07-01 | ファイザー・インク | Ｉｌ−１５バリアントおよびその使用 |
| KR20210113265A (ko) * | 2019-01-07 | 2021-09-15 | 인히브릭스, 인크. | 변형된 il-2 폴리펩타이드를 포함하는 폴리펩타이드 및 이의 용도 |
-
2021
- 2021-12-08 CN CN202180093384.4A patent/CN116829194A/zh active Pending
- 2021-12-08 WO PCT/US2021/062484 patent/WO2022125711A1/en not_active Ceased
- 2021-12-08 KR KR1020237022145A patent/KR20230129983A/ko active Pending
- 2021-12-08 US US18/256,512 patent/US20240043490A1/en active Pending
- 2021-12-08 JP JP2023559969A patent/JP2023553216A/ja active Pending
- 2021-12-08 EP EP21904356.9A patent/EP4259213A4/en active Pending
- 2021-12-08 CA CA3201573A patent/CA3201573A1/en active Pending
- 2021-12-08 AU AU2021397271A patent/AU2021397271A1/en active Pending